Treatment interventions for Parkinson's disease: an evidence based assessment

This publication has 90 references indexed in Scilit:

• Quetiapine
  CNS Drugs, 2000
• Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial
  The Lancet, 1999
• Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study
  Journal of Neurology, Neurosurgery & Psychiatry, 1999
• Levodopa in Parkinson??s Disease
  Drug Safety, 1999
• Ropinirole in the Treatment of Levodopa-Induced Motor Fluctuations in Patients with Parkinson's Disease
  Clinical Neuropharmacology, 1996
• Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
• A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
  Journal of Neurology, Neurosurgery & Psychiatry, 1994
• Potential of Neuroprotective Therapy in Parkinsonʼs Disease
  CNS Drugs, 1994
• Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
  BMJ, 1993
• Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
  New England Journal of Medicine, 1989